NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 57 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $193,000 | -31.6% | 361,377 | -13.3% | 0.00% | – |
| Q2 2020 | $282,000 | +46.1% | 416,944 | +24.4% | 0.00% | – |
| Q1 2020 | $193,000 | -64.3% | 335,215 | -18.0% | 0.00% | – |
| Q4 2019 | $540,000 | -23.6% | 408,570 | +15.6% | 0.00% | – |
| Q3 2019 | $707,000 | +9.6% | 353,322 | +33.1% | 0.00% | – |
| Q2 2019 | $645,000 | +52.1% | 265,418 | +52.9% | 0.00% | – |
| Q1 2019 | $424,000 | +52.5% | 173,549 | -8.7% | 0.00% | – |
| Q4 2018 | $278,000 | -45.5% | 190,044 | +0.6% | 0.00% | – |
| Q3 2018 | $510,000 | +73.5% | 188,931 | +123.8% | 0.00% | – |
| Q2 2018 | $294,000 | +34.9% | 84,434 | +94.3% | 0.00% | – |
| Q1 2018 | $218,000 | +165.9% | 43,461 | +215.8% | 0.00% | – |
| Q4 2017 | $82,000 | -99.2% | 13,764 | -98.9% | 0.00% | -100.0% |
| Q3 2017 | $10,360,000 | +345233.3% | 1,264,924 | +446869.6% | 0.00% | – |
| Q2 2017 | $3,000 | – | 283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |